Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

Total article views   HTML views PDF downloads Totals
11,773 Dovepress* 10,080+ 1,957 12,037
PubMed Central* 1,693 688 2,381
Totals 11,773 2,645 14,418
*Since 20 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar